Literature DB >> 28025780

Exosomes in Parkinson's Disease.

Xiaoqing Wu1, Tingting Zheng2, Baorong Zhang3.   

Abstract

Exosomes, nano-sized extracellular vesicles secreted by most cell types, are found in all kinds of biological fluids and tissues, including the central nervous system (CNS). The proposed functions of these vesicles include roles in cell-cell signaling, removal of cellular debris, and transfer of pathogens between cells. Many studies have revealed that exosomes derived from the CNS occur in the cerebrospinal fluid and peripheral body fluids, and their contents are altered during disease, making them an appealing target for biomarker development in Parkinson's disease (PD). Exosomes have been shown to spread toxic α-synuclein (αsyn) between cells and induce apoptosis, which suggests a key mechanism underlying the spread of αsyn aggregates in the brain and the acceleration of pathology in PD. However, potential neuroprotective roles of exosomes in PD have also been reported. On the treatment side, as drug delivery vehicles, exosomes have been used to deliver small interfering RNAs and catalase to the brain, and have shown clear therapeutic effects in a mouse model of PD. These features of exosomes in PD make them extremely interesting from the point of view of developing novel diagnostic and therapeutic approaches.

Entities:  

Keywords:  Biomarker; Exosomes; Parkinson’s disease; Pathology; Therapy

Mesh:

Year:  2016        PMID: 28025780      PMCID: PMC5567508          DOI: 10.1007/s12264-016-0092-z

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  91 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  Identification and proteomic profiling of exosomes in human urine.

Authors:  Trairak Pisitkun; Rong-Fong Shen; Mark A Knepper
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

3.  Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules.

Authors:  H F Heijnen; A E Schiel; R Fijnheer; H J Geuze; J J Sixma
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

4.  Endosome-to-cytosol transport of viral nucleocapsids.

Authors:  Isabelle Le Blanc; Pierre-Philippe Luyet; Véronique Pons; Charles Ferguson; Neil Emans; Anne Petiot; Nathalie Mayran; Nicolas Demaurex; Julien Fauré; Rémy Sadoul; Robert G Parton; J Gruenberg
Journal:  Nat Cell Biol       Date:  2005-06-12       Impact factor: 28.824

5.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

Review 6.  Exosomes as a potential novel therapeutic tools against neurodegenerative diseases.

Authors:  Akvilė Jarmalavičiūtė; Augustas Pivoriūnas
Journal:  Pharmacol Res       Date:  2016-02-06       Impact factor: 7.658

Review 7.  Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.

Authors:  David R P Guay
Journal:  Am J Geriatr Pharmacother       Date:  2006-12

8.  Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation.

Authors:  Marcel Kunadt; Katrin Eckermann; Anne Stuendl; Jing Gong; Belisa Russo; Katrin Strauss; Surya Rai; Sebastian Kügler; Lisandro Falomir Lockhart; Martin Schwalbe; Petranka Krumova; Luis M A Oliveira; Mathias Bähr; Wiebke Möbius; Johannes Levin; Armin Giese; Niels Kruse; Brit Mollenhauer; Ruth Geiss-Friedlander; Albert C Ludolph; Axel Freischmidt; Marisa S Feiler; Karin M Danzer; Markus Zweckstetter; Thomas M Jovin; Mikael Simons; Jochen H Weishaupt; Anja Schneider
Journal:  Acta Neuropathol       Date:  2015-03-17       Impact factor: 17.088

9.  Identification of distinct circulating exosomes in Parkinson's disease.

Authors:  Paul R Tomlinson; Ying Zheng; Roman Fischer; Ronny Heidasch; Chris Gardiner; Samuel Evetts; Michele Hu; Richard Wade-Martins; Martin R Turner; John Morris; Kevin Talbot; Benedikt M Kessler; George K Tofaris
Journal:  Ann Clin Transl Neurol       Date:  2015-02-06       Impact factor: 4.511

10.  Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.

Authors:  Anne Stuendl; Marcel Kunadt; Niels Kruse; Claudia Bartels; Wiebke Moebius; Karin M Danzer; Brit Mollenhauer; Anja Schneider
Journal:  Brain       Date:  2015-12-08       Impact factor: 13.501

View more
  34 in total

1.  Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.

Authors:  Richard A Maki; Michael Holzer; Khatereh Motamedchaboki; Ernst Malle; Eliezer Masliah; Gunther Marsche; Wanda F Reynolds
Journal:  Free Radic Biol Med       Date:  2019-06-06       Impact factor: 7.376

2.  Extracellular α-Synuclein Modulates Iron Metabolism Related Proteins via Endoplasmic Reticulum Stress in MES23.5 Dopaminergic Cells.

Authors:  Xiaoqing Mi; Qijun Li; Xiaoming Wen; Junxia Xie; Youcui Wang; Ning Song
Journal:  Neurochem Res       Date:  2021-03-11       Impact factor: 3.996

3.  CSF-Based Analysis for Identification of Potential Serum Biomarkers of Neural Tube Defects.

Authors:  Xinyu Yan; Lixin Mai; Changchun Lin; Wenji He; Gengsheng Yin; Jiakang Yu; Lian Huang; Sanqiang Pan
Journal:  Neurosci Bull       Date:  2017-07-10       Impact factor: 5.203

4.  Poly-PR in C9ORF72-Related Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Causes Neurotoxicity by Clathrin-Dependent Endocytosis.

Authors:  Rui Wang; Xingyun Xu; Zongbing Hao; Shun Zhang; Dan Wu; Hongyang Sun; Chenchen Mu; Haigang Ren; Guanghui Wang
Journal:  Neurosci Bull       Date:  2019-05-30       Impact factor: 5.203

Review 5.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

6.  Alpha-Synuclein Handling by Microglia: Activating, Combating, and Worsening.

Authors:  Ning Song; Leilei Chen; Junxia Xie
Journal:  Neurosci Bull       Date:  2021-03-20       Impact factor: 5.203

Review 7.  Exosomes in Alzheimer's Disease: Potential Role as Pathological Mediators, Biomarkers and Therapeutic Targets.

Authors:  Sreeja Lakshmi; Musthafa Mohamed Essa; Richard E Hartman; Gilles J Guillemin; Sureshkumar Sivan; Preetham Elumalai
Journal:  Neurochem Res       Date:  2020-08-25       Impact factor: 3.996

8.  Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson's Disease.

Authors:  Kyu Hwan Shim; Han Gyeol Go; Heewon Bae; Da-Eun Jeong; Danyeong Kim; Young Chul Youn; SangYun Kim; Seong Soo A An; Min Ju Kang
Journal:  Front Aging Neurosci       Date:  2021-05-28       Impact factor: 5.750

Review 9.  Exosomes: Origins and Therapeutic Potential for Neurodegenerative Disease.

Authors:  Diana K Sarko; Cindy E McKinney
Journal:  Front Neurosci       Date:  2017-02-27       Impact factor: 4.677

10.  The Exosomal/Total α-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients.

Authors:  Silvia Cerri; Cristina Ghezzi; Maria Sampieri; Francesca Siani; Micol Avenali; Gianluca Dornini; Roberta Zangaglia; Brigida Minafra; Fabio Blandini
Journal:  Front Cell Neurosci       Date:  2018-05-18       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.